Ovarian Cancer Trial May Help 30% More Patients

October 16, 2019

Ovarian Cancer Trial May Help 30% More Patients

Cancer patients at the Sylvester Comprehensive Cancer Center that participated in a clinical trial for ovarian cancer have impacted the way the disease is understood. The study proved that an anti-cancer drug called veliparib, which targets the way DNA repairs itself, might help up to 30% more patients. Yourway increases access to life-saving medicine by being on the forefront of the clinical trial supply chain.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Pharma Supply Chain & Logistics Innovation Programme EU

May 20-21, 2026
Basel, Switzerland

Schedule a Meeting

Clinical Trial Supply West Coast

September 22-23, 2026
Burlingame, CA

Schedule a Meeting

Media

Articles

Global Reach in Clinical Trials: Beyond Presence to True Execution

Open chat

Hello! How can I help you?